Ascendis Pharma A/S(ASND) Stock Price Today | Quotes & News - Moomoo

English
中文繁體
中文简体

Dark
Light

Open Account

US Stock MarketDetailed Quotes

ASND Ascendis Pharma A/S

Watchlist

161.040
-6.950-4.14%

Close Mar 25 16:00 ET

163.040
+2.000+1.24%

Post 20:01 ET

9.68BMarket Cap-22.85P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Here's How Much $100 Invested In Ascendis Pharma 15 Years Ago Would Be Worth Today
Benzinga12:45 ET
European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading
MT NewswiresMar 19 11:03 ET
J.P. Morgan Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Raises Target Price to $200
Moomoo NewsMar 19 02:32 ET · Ratings
Ascendis Pharma Price Target Raised to $200.00/Share From $168.00 by JP Morgan
Dow JonesMar 18 08:38 ET · Ratings
Ascendis Pharma Is Maintained at Overweight by JP Morgan
Dow JonesMar 18 08:38 ET · Ratings
Wedbush Maintains Ascendis Pharma A/S(ASND.US) With Buy Rating, Maintains Target Price $181
Moomoo NewsMar 18 02:33 ET · Ratings

Comments

DayTradingWithTroy

$Ascendis Pharma A/S (ASND.US)$

Oct 10, 2024 01:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$

1

Sep 19, 2024 21:28

$Ascendis Pharma A/S (ASND.US)$ big rebound from drop after financials , from 111 to 150. that's a good profit for those who payed attention. $NVIDIA (NVDA.US)$ $Apple (AAPL.US)$

1

Sep 5, 2024 21:46

$Ascendis Pharma A/S (ASND.US)$ reporting wasn't so terrible that it deserves a15% drop. could see this rebounding above the price before the drop

1

Aug 21, 2024 15:00

FDA PDUFA Update…

🚨 This Week’s PDUFAs:
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Linvoseltamab
‣ Multiple myeloma
‣ PDUFA: 8/22/24 (BLA)
🗓️ Last Week’s PDUFAs:
$Gilead Sciences (GILD.US)$ : Approved 8/14 🎉
⇨ Livdelzi (Seladelpar)
‣ Primary biliary cholangitis (PBC)
‣ PDUFA: 8/14/24 (NDA)
$Ascendis Pharma A/S (ASND.US)$ : Approved 8/12 🎉
⇨ YORVIPATH (palopegteriparatide)
‣ Hypoparathyroidism
‣ PDUFA: 8/14/24 (NDA)
$Syndax Pharmaceuticals (SNDX.US)$ & $Incyte (INCY.US)$ : Approved 8/14 🎉
⇨ Nikt...

8

Read more